longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

PepGen(PEPG.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

PepGen Files $400 Million Mixed Shelf

fidelity·Yesterday at 00:23
US
PEPG
-6.12%
US
PBE
+0.11%
US
FBT
+0.54%
fidelity·Yesterday at 00:23
US
PEPG
-6.12%
US
PBE
+0.11%
US
FBT
+0.54%

PepGen Inc. Stock 12‑Month Price Target Cut to $10, Implies 495% Upside

TradingView·05/14/2026 00:20
US
PEPG
-6.12%
US
IBB
+0.10%
US
LABU
-2.35%
TradingView·05/14/2026 00:20
US
PEPG
-6.12%
US
IBB
+0.10%
US
LABU
-2.35%

Wedbush Keeps Their Buy Rating on PepGen Inc. (PEPG)

Tip Ranks·05/13/2026 20:37
US
PEPG
-6.12%
US
ARKG
+0.04%
US
IBB
+0.10%
Tip Ranks·05/13/2026 20:37
US
PEPG
-6.12%
US
ARKG
+0.04%
US
IBB
+0.10%

PepGen | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/13/2026 04:20
US
PEPG
-6.12%
Earnings Watch·05/13/2026 04:20
US
PEPG
-6.12%

PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages

Market Beat·04/13/2026 16:34
US
PEPG
-6.12%
US
SBIO
-1.24%
US
BBH
+0.68%
Market Beat·04/13/2026 16:34
US
PEPG
-6.12%
US
SBIO
-1.24%
US
BBH
+0.68%

Top 3 Health Care Stocks Which Could Blast Off This Quarter

benzinga_article·04/08/2026 18:40
US
IXJ
+0.79%
US
SBIO
-1.24%
US
VRDN
-0.81%
benzinga_article·04/08/2026 18:40
US
IXJ
+0.79%
US
SBIO
-1.24%
US
VRDN
-0.81%

21:44 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

prnewswire·04/03/2026 09:45
US
LABU
-2.35%
US
XBI
-0.69%
US
VHT
+0.97%
prnewswire·04/03/2026 09:45
US
LABU
-2.35%
US
XBI
-0.69%
US
VHT
+0.97%
© 2026 Longbridge|Disclaimer

Event Tracking

May13
PepGen released FY2026 Q1 earnings on May 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.26 (forecast USD -0.312)
03:00
Mar5
PepGen released FY2025 Q4 earnings on March 4, 2026 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2666 (forecast USD -0.3742)
04:00
PepGen released FY2025 Annual Earnings on March 4, 2026 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -2.1234 (forecast USD -2.1628)
04:00
Nov13
PepGen released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5245 (forecast USD -0.565)
04:00
PepGen released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -2.1538
04:00
Oct2
PepGen to showcase positive clinical data for neuromuscular therapies
11:01

Schedules & Filings

Schedules
Filings
May12
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -17.76 M, EPS -0.26

Mar4
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -18.34 M, EPS -0.2666

Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -18.03 M, EPS -0.5245

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INM
1.600
+135.05%
+0.919
AMPGZ
0.5800
+132.00%
+0.330
AMST
1.730
+120.07%
+0.944
CNEY
1.610
+119.77%
+0.877
AMPGR
0.5000
+102.02%
+0.253
NXXT
0.8201
+100.02%
+0.410
WNW
4.750
+97.10%
+2.340
GIPR
0.4290
+75.89%
+0.185
MTVA
1.880
+69.37%
+0.770
SVRN
8.200
+49.64%
+2.720
View More